<a href="https://pubmed.ncbi.nlm.nih.gov/31320597/" rel="nofollow noopener noreferrer ugc" target="_blank">https://pubmed.ncbi.nlm.nih.gov/31320597/</a> <br> <br> Wow 23 authors on an article on ICT-107 <b>P2</b> trial which ended up being as effective as DCVax will be. <br> <br> Number of authors of a publication are irrelevant to success. <br> <br> The DCVax P3 trial has over 80 locations. 60+ in the US. Each with a lead (who wants to be published). I'll bet that for every US location that actually had a patient enrolled, the lead got an "author" credit in that now 3 year old publication.